Techcyte has announced a significant milestone, with a validation study of its AI-assisted ova and parasite (O&P) workflow receiving acceptance for presentation at the upcoming APHL 2026 Annual Conference. Conducted by the Contra Costa County Public Health Laboratory (CCPHL), the study showcases the potential of Techcyte’s parasitology suite, which integrates trichrome and wet mount solutions with an automated whole slide imager provided by Pramana, now known as Evident.
In light of increasing specimen volumes and staffing challenges, the study highlights the efficacy of an AI-assisted digital workflow to bolster existing screening processes. Over the evaluation period, 549 patient samples, each consisting of paired trichrome and wet mount slides, were analyzed, achieving an impressive 97% accuracy, 98% sensitivity, and 97% specificity. The results, which utilized both newly received and archived specimens, were benchmarked against traditional microscopy methods, showcasing a reduction in turnaround times and enhanced workflow efficiency upon implementation in January 2026.
The study authors emphasize that AI integration within public health laboratory processes could be pivotal in addressing workforce shortages while upholding standard diagnostic protocols. Notably, the confirmation of positive cases is still conducted using conventional light microscopy. Tyler Rippy, Account Executive at Techcyte, expressed satisfaction with the collaboration with CCPHL, highlighting the study’s role in promoting AI-assisted workflows in parasitology laboratories.
Techcyte’s comprehensive digital parasitology solution is designed to support various staining methods, such as trichrome, wet mount, and modified acid-fast (MAF), within a cohesive workflow. Although the Contra Costa County Public Health Laboratory does not endorse specific products, it has incorporated the evaluated platform into its operations, attesting to its practical utility.
Founded in 2013, Techcyte is committed to enhancing human, animal, and environmental health through artificial intelligence. By collaborating with leading labs, scanner manufacturers, AI vendors, diagnostic companies, hardware manufacturers, and solution providers, Techcyte aims to deliver a unified anatomic and clinical pathology platform globally. The company will showcase its offerings at Booth 201 during the APHL 2026 Annual Conference, scheduled for May 4–7 in Baltimore.